RE: RE: RE: RE: requeirm lol are you delusional? You're gonna keep on with this farce until the CCAA notice? Sounds like you've been in a coma because I know exactly where MKI is. I made money on this dog twice. Once from about 30 cents to about 80 cents (when it was 4 cents the previous day) then a second time from 18 to about 20 14 months ago. I probably sold my shares to you and you're the one waking from a coma, down 85% in just over a year. I'll be honest I didn't think MKI was a dog at the time, but I knew it was just a pump when nearly 2 years after FDA approval and they still have almost no revenue and are racking up dangerous levels of debt. The reason why FDA approval is such a big mover for biotech stocks is that it's meant to be the final hurdle - meaning you're supposed to have millions in revenue a fw months later. Not $100K a quarter two years later. Look at EKG for example one year after their FDA approval now they are getting the purchase orders in.
You know I speak the truth. The only reason you're so mad at me is that whatever little influence these bullboards have, I have put an end to any chance your inane pumping will lift this stock. There's no chance you can even move this stock to 5 cents now so you can exit at a somewhat recoverable price. The company can't finance through equity without a reverse split. You're basically in hail mary mode where you're hoping something, anything leads this company to something other than CCAA. A buyout, a sale, a partnership, refinancing of the debt (that's very unlikely imo in this TSX Venture climate). Revenue itself is not going to do it. It's at least 2 years of steady growth away just to breakeven, let alone the issues with the timing of the debt coming due. The ultimate slap in the face would be if they sell their iaHealth division in desperation to stay afloat because that's the only one with value at the moment. The goodwill writedown shows what they think of their recent acquisition.